Abstract

EE327 Cost-Effectiveness Analysis of Cemiplimab for Patients With Advanced Non-Small Cell Lung Carcinoma in Spain

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
The role for chemotherapy in 80 years and older patients with metastatic non-small cell lung cancer: A National cancer database analysis
Zaheer Ahmed ... Janakiraman Subramanian
Lung cancer (Amsterdam, Netherlands) | VOL. 154
Zaheer Ahmed, et. al.Zaheer Ahmed ... Janakiraman Subramanian
16 Feb 2021
Study of pretreatment serum levels of HER-2/neu oncoprotein as a prognostic and predictive factor in patients with advanced nonsmall cell lung carcinoma
Andrea Ardizzoni ... Riccardo Puntoni
Cancer | VOL. 92
Andrea Ardizzoni, et. al.Andrea Ardizzoni ... Riccardo Puntoni
01 Jan 2001
Study of pretreatment serum levels of HER‐2/neu oncoprotein as a prognostic and predictive factor in patients with advanced nonsmall cell lung carcinoma
Andrea Ardizzoni ... Paola Marroni
Cancer | VOL. 92
Andrea Ardizzoni, et. al.Andrea Ardizzoni ... Paola Marroni
01 Oct 2001
Phase I/II trial of paclitaxel by 1-hour infusion, carboplatin, and gemcitabine in the treatment of patients with advanced nonsmall cell lung carcinoma.
John D Hainsworth ... Leonard A Kalman
Cancer | VOL. 85
John D Hainsworth, et. al.John D Hainsworth ... Leonard A Kalman
15 Mar 1999
View more papers

More From: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Paper Title
Journal
Date
Author
The Functional Assessment of Cancer Therapy Eight Dimension (FACT-8D), a Multi-Attribute Utility Instrument Derived From the Cancer-Specific FACT-General (FACT-G) Quality of Life Questionnaire: Development and Australian Value Set
-
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
--
21 Jun 2024
Market entry agreements for innovative pharmaceuticals subject to indication broadening: a case study for pembrolizumab in the Netherlands.
Renaud J S D Heine ... Carin A Uyl-De Groot
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
Renaud J S D Heine, et. al.Renaud J S D Heine ... Carin A Uyl-De Groot
21 Jun 2024
MSR99 A Stacked Ensemble Approach for Building Composite Measure Models in Healthcare
P Shi ... S Zhang
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. 27
P Shi, et. al.P Shi ... S Zhang
15 Jun 2024
EE98 A Theory-Based Framework to Incorporate Health Equity in Economic Assessments
S Subramanian ... S Hoover
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. 27
S Subramanian, et. al.S Subramanian ... S Hoover
15 Jun 2024
View more papers